Drug shop regulation and malaria treatment in Tanzania - Why do shops break the rules, and does it matter?

Health Policy and Planning

Volumn 22, Issue 6, 2007, Pages 393-403

  Goodman, Catherine ^a,b   Kachur, S Patrick ^c,d   Abdulla, Salim ^c   Bloland, Peter ^e   Mills, Anne ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

^c IFAKARA HEALTH INSTITUTE   (Tanzania)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

Drugs; Malaria; Private sector; Regulation; Shopkeepers

Indexed keywords

ALTERNATIVE MEDICINE; ARTICLE; DRUG INDUSTRY; DRUG STORAGE; LOWEST INCOME GROUP; MALARIA; TANZANIA;

COMMUNITY PHARMACY SERVICES; GOVERNMENT REGULATION; GUIDELINE ADHERENCE; HUMANS; INTERVIEWS AS TOPIC; MALARIA; PRIVATE SECTOR; TANZANIA;

EID: 36249028849     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czm033     Document Type: Article

References (56)

1. Adikwu MU. 1996. Sales practices of patent medicine sellers in Nigeria. Health Policy and Planning 11: 202-5.
2. Adome RO, Whyte SR, Hardon A. 1996. Popular pills: community drug use in Uganda. Amsterdam: Het Spinhuis.
3. Amin AA, Hughes DA, Marsh V et al. 2004. The difference between effectiveness and efficacy of antimalarial drugs in Kenya. Tropical Medicine and International Health 9: 967-74.
4. Attanayake N, Siyambalagoda L. 2003. An inquiry into the regulation of pharmaceutical and medical practice in Sri Lanka. HEFP Working Paper 05/03. London: London School of Hygiene and Tropical Medicine, Health Economics & Financing Programme. Online at: http://www.hefp.lshtm.ac.uk/publications/ downloads/working_papers/05_03.pdf.
5. Basco LK. 2004. Molecular epidemiology of malaria in Cameroon. XIX. Quality of antimalarial drugs used for self-medication. American Journal of Tropical Medicine and Hygiene 70: 245-50.
6. Battersby A, Goodman C, Abondo C, Mandike R. 2003. Improving the supply, distribution and use of antimalarial drugs by the private sector in Tanzania. London: Malaria Consortium.
7. Bennett S, Dakpallah G, Garner P et al. 1994. Carrot and stick: state mechanisms to influence private provider behavior. Health Policy and Planning 9: 1-13.
8. Berman P. 2000. Organization of ambulatory care provision: a critical determinant of health system performance in developing countries. Bulletin of the World Health Organization 78: 791-802.
9. Bloom GH, Standing H. 2001. Pluralism and marketisation in the health sector: meeting health needs in contexts of social change in low and middle-income countries. IDS Working Paper 136. Brighton: Institute of Development Studies.
10. Brieger WR. 2002. The role of patent medicine vendors in the management of sick children in the African region. Arlington, VA: BASICS II.
11. Brieger WR, Unwin A, Greer G, Meek S. 2004. Interventions to improve the role of informal private providers in malaria case management for children in Africa. BASICS II and the Malaria Consortium; prepared for The Malaria Case Management Working Group, Roll Back Malaria. Online at: http://www.rbm.who.int/ partnership/wg/wg_management/docs/medsellersRBMmtgsubcommitteereport.pdf.
12. Brugha R, Zwi AB. 1999. Sexually transmitted disease control in developing countries: the challenge of involving the private sector. Sexually Transmitted Infections 75: 283-5.
13. Chalker J, Ratanawijitrasin S, Chuc NT et al. 2005. Effectiveness of a multi-component intervention on dispensing practices at private pharmacies in Vietnam and Thailand - a randomized controlled trial. Social Science and Medicine 60: 131-41.
14. Fassin D. 1988. Illicit sale of pharmaceuticals in Africa: sellers and clients in the suburbs of Dakar. Tropical and Geographical Medicine 40: 166-70.
15. Font F, Alonso Gonzalez M, Nathan R et al. 2001. Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania. Tropical Medicine and International Health 6: 423-8.
16. Goel P, Ross Degnan D, Berman P, Soumerai S. 1996. Retail pharmacies in developing countries: a behavior and intervention framework. Social Science and Medicine 42: 1155-61.
17. Goodman C, Kachur SP, Abdulla S et al. 2004. Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities. Tropical Medicine and International Health 9: 655-63.
18. Goodman CA. 2004. An economic analysis of the retail market for fever and malaria treatment in rural Tanzania. PhD Thesis, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, University of London.
19. Greenwood BM, Bradley AK, Greenwood AM et al. 1987. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 81: 478-86.
20. Hammer JST. 1992. To prescribe or not to prescribe: on the regulation of pharmaceuticals in less developed countries. Social Science and Medicine 34: 959-64.
21. Hill M, Hupe P. 2002. Implementing public policy. Thousand Oaks, CA: Sage.
22. Hongoro C, Kumaranayake L. 2000. Do they work? Regulating for-profit providers in Zimbabwe. Health Policy and Planning 15: 368-77.
23. Kachur SP, Schulden J, Goodman CA et al. 2006. Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004. Tropical Medicine and International Health 11: 441-51.
24. Kumaranayake L. 1997. The role of regulation: influencing private sector activity within health sector reform. Journal of International Development 9: 641-9.
25. Kumaranayake L. 1998. Economic aspects of health sector regulation: Strategic choices for low and middle income countries. PHP Departmental Publication No. 29. London: London School of Hygiene and Tropical Medicine, Department of Public Health and Policy.
26. Kumaranayake L, Lake S, Mujinja P et al. 2000. How do countries regulate the health sector? Evidence from Tanzania and Zimbabwe. Health Policy and Planning 15: 357-67.
27. Kumaranayake L, Hongoro C, Lake S et al. 2003. Coping with private health markets - regulatory (in)effectiveness in sub-Saharan Africa. In: Soderlund N, Mendoza-Arana P, Goudge J (eds). The new public/private mix in health: exploring the changing landscape. Geneva: Alliance for Health Policy and Systems Research.
28. Kurowski C, Wyss K, Abdulla S et al. 2004. Human resources for health: Requirements and availability in the context of scaling-up priority interventions in low-income countries. Case studies from Tanzania and Chad. HEFP Working Paper 01/04 London: London School of Hygiene and Tropical Medicine, Health Economics & Financing Programme.
29. Lipsky M. 1980. Street-level bureaucracy; dilemmas of the individual in public services. New York: Russell Sage Foundation.
30. Mackintosh M, Tibandebage P. 2002. Inclusion by design? Rethinking healthcare market regulation in the Tanzanian context. Journal of Development Studies 39: 1-20.
31. Mbwasi R. 2005. Enhancing access to medicines through private and multisector initiatives: The Tanzania experience. In Proceedings of the Strategies for Enhancing Access to Medicines (SEAM) Conference on Targeting Improved Access to Essential Medicines, 20-22 June 2005, Accra, Ghana.
32. McCombie SC. 2002. Self-treatment for malaria: the evidence and methodological issues. Health Policy and Planning 17: 333-44.
33. Meyers MK, Vorsanger S. 2002. Street-level bureaucrats and the implementation of public policy. In: Peters BG, Pierre J (eds). Handbook of public administration. Thousand Oaks, CA: Sage, pp. 245-55.
34. Ministry of Health. 1998. Guidelines for dealing in Part II poisons. Prepared by the Pharmacy Board, Ministry of Health, Dar es Salaam. Tanzania.
35. Minzi OM, Moshi MJ, Hipolite D et al. 2003. Evaluation of the quality of amodiaquine and sulphadoxine/pyrimethamine tablets sold by private wholesale pharmacies in Dar Es Salaam Tanzania. Journal of Clinical Pharmacy and Therapeutics 28: 117-22.
36. Murray J, Mosazghi A, Kifleysus B, Orobaton N. 1998. Rural drug vendors in Eritrea: a study of practices and training needs. Arlington, VA: Basic Support for Institutionalizing Child Survival (BASICS) Project, for USAID.
37. National Malaria Control Programme. 2002. Assessment of malaria situation and control activities in Tanzania, 2001. Dar es Salaam: Ministry of Health, United Republic of Tanzania.
38. Nsimba SED, Warsame M, Tomson G et al. 1999. A household survey of source, availability and use of antimalarials in a rural area of Tanzania. Drug Information Journal 33: 1025-32.
39. Ogwal Okeng JW, Okello DO, Odyek O. 1998. Quality of oral and parenteral chloroquine in Kampala. East African Medical Journal 75: 692-4.
40. Oshiname FO, Brieger WR. 1992. Primary care training for patent medicine vendors in rural Nigeria. Social Science and Medicine 35: 1477-84.
41. Pressman JL, Wildavsky A. 1973. Implementation. Berkeley, CA: University of California Press.
42. Reynolds Whyte S, Birungi H. 2000. The business of medicines and the politics of knowledge. In: Whiteford L, Manderson L (eds). Globalization, health and identity: the fallacy of the level playing field. Boulder, CO: Lynne Rienner.
43. Risha PG, Shewiyo D, Msami A et al. 2002. In vitro evaluation of the quality of essential drugs on the Tanzanian market. Tropical Medicine and International Health 7: 701-7.
44. Schellenberg D, Aponte J, Kahigwa E et al. 2003. The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 97: 1-8.
45. Shakoor O, Taylor RB, Behrens RH. 1997. Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health 2: 839-45.
46. Sigonda-Ndomondo M, Mbwasi R, Shirima R et al. 2004. Accredited drug dispensing outlets: improving access to quality drugs and services in rural and peri-urban areas with few or no pharmacies. Presentation at the Second International Conference on Improving Use of Medicines, 30 March - 2 April, Chiang Mai, Thailand.
47. Smith E, Brugha R, Zwi A. 2001. Working with private sector providers for better health care: an introductory guide. London: Options and London School of Hygiene and Tropical Medicine.
48. Stata Inc. 2003. Survey data reference manual. College Station, TX: Stata Press.
49. Stenson B, Syhakhang L, Lundborg CS et al. 2001. Private pharmacy practice and regulation. A randomized trial in Lao P.D.R. International Journal of Technology Assessment in Health Care 17: 579-89.
50. Tawfik Y, Northrup R, Prysor-Jones S. 2002. Utilizing the potential of formal and informal private practitioners in child survival: situation analysis and summary of promising interventions. Washington, DC: Support for Analysis and Research in Africa (SARA) Project, Academy for Educational Development. Online at: http://pdf.usaid.gov/pdf_docs/PNACP202.pdf.
51. Taylor RB, Shakoor O, Behrens RH et al. 2001. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. The Lancet 357: 1933-6.
52. Uplekar M, Juvekar S, Morankar S et al. 1998. Tuberculosis patients and practitioners in private clinics in India. International Journal of Tuberculosis and Lung Disease 2: 324-9.
53. van der Geest S. 1987. Self-care and the informal sale of drugs in south Cameroon. Social Science and Medicine 25: 293-305.
54. Waters H, Hatt L, Peters D. 2003. Working with the private sector for child health. Health Policy and Planning 18: 127-37.
55. WHO. 2004. Scaling up home-based management of malaria. Document WHO/HTM/MAL/2004.1096. Geneva: World Health Organization, Roll Back Malaria Department/UNICEF/UNDP/World Bank/TDR.
56. Williams HA, Jones CO. 2004. A critical review of behavioral issues related to malaria control in sub-Saharan Africa: what contributions have social scientists made? Social Science and Medicine 59: 501-23.